Evidence map›Paper›PMID 39576574›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2025

Improving Protein Secondary Structure Prediction by Deep Language Models and Transformer Networks.

Tianqi Wu, Weihang Cheng, Jianlin Cheng

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Tianqi WuElectrical Engineering and Computer Science Department, University of Missouri, Columbia, MO, USA.
Weihang ChengDepartment of Chemistry, Hubei University, Wuhan, Hubei, China.
Jianlin ChengElectrical Engineering and Computer Science Department, University of Missouri, Columbia, MO, USA. chengji@missouri.edu.

Funding

Integrated Prediction of Protein Struture at 1D, 2D and 3D LevelsR01GM093123 · NIGMS · UNIVERSITY OF MISSOURI-COLUMBIA · PI CHENG, JIANLIN · 2010 to 2023
$3.8M
National Science Foundation DBI1759934National Science Foundation IIS1763246NIGMS NIH HHS R01 GM093123
6 · The paper itself

Abstract

Protein secondary structure prediction is useful for many applications. It can be considered a language translation problem, that is, translating a sequence of 20 different amino acids into a sequence of secondary structure symbols (e.g., alpha helix, beta strand, and coil). Here, we develop a novel protein secondary structure predictor called TransPross based on the transformer network and attention mechanism widely used in natural language processing to directly extract the evolutionary information from the protein language (i.e., raw multiple sequence alignment [MSA] of a protein) to predict the secondary structure. The method is different from traditional methods that first generate a MSA and then calculate expert-curated statistical profiles from the MSA as input. The attention mechanism used by TransPross can effectively capture long-range residue-residue interactions in protein sequences to predict secondary structures. Benchmarked on several datasets, TransPross outperforms the state-of-art methods. Moreover, our experiment shows that the prediction accuracy of TransPross positively correlates with the depth of MSAs, and it is able to achieve the average prediction accuracy (i.e., Q3 score) above 80% for hard targets with few homologous sequences in their MSAs. TransPross is freely available at https://github.com/BioinfoMachineLearning/TransPro .

Indexed as

Computational BiologyProteinsProtein Structure, SecondaryAlgorithmsAmino Acid SequenceDatabases, ProteinDeep LearningSequence AlignmentSoftwareProteinsAttentionNatural language processingProtein secondary structure predictionTransformer

Identifiers

PMID39576574

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.